To determine the effect of dapagliflozin therapy on beta cell function and insulin sensitivity in patients with newly diagnosed T2D, we compared HOMA-B and HOMA-IR at 1 week of treatment and the endpoint after treatment completion between the two groups. Here, INS is linked to type 2 diabetes mellitus.